IONS

#780
Ionis Pharmaceuticals, Inc. - Common Stock
77.6 9 USD
+0.47%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
77.09
78.10
Range Annuel
0.75
86.74
Changement quotidien
+0.47%
Changement Mensuel
+4.14%
Evolution sur 6 mois
-5.29%
Changement Annuel
+7.72%
Clôture Précédente
77.3 3
Open
77.6 0
Low
77.0 9
High
78.1 0
Volume
149
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 12.84 B
  • Employee 1 402
  • Founded 1989
  • CEO Brett P. Monia Ph.D.
  • Website www.ionis.com
  • Headquarter California, United States
  • FIGI BBG000JH6683
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-33.24
ratio cours/chiffre d'affaires
13.41

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.

Nouvelles